|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| C12N 15/11 |
| (11) | Patento numeris | 3067421 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16154927.4 |
| Europos patento paraiškos padavimo data | 2012-02-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-09-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161440828 P | 2011-02-08 | US | |
| 201161470927 P | 2011-04-01 | US | |
| 201161522659 P | 2011-08-11 | US |
| (72) |
FREIER, Susan, M., US
SWAYZE, Eric, E., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF |
| OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF |